Inherited disorders of the blood, such as sickle-cell anaemia and thalassaemia, result from mutations in the genes that produce haemoglobin. Current treatments can partially alleviate some of the debilitating symptoms of these diseases but these treatments have significant side effects, and despite the best efforts of clinicians, many patients succumb to their conditions at an early age. It has been observed that certain individuals exhibit a milder form of the disease, as a consequence of the r ....Inherited disorders of the blood, such as sickle-cell anaemia and thalassaemia, result from mutations in the genes that produce haemoglobin. Current treatments can partially alleviate some of the debilitating symptoms of these diseases but these treatments have significant side effects, and despite the best efforts of clinicians, many patients succumb to their conditions at an early age. It has been observed that certain individuals exhibit a milder form of the disease, as a consequence of the reactivation of their foetal haemoglobin genes, (a distinct set of genes that would have been active in utero but are normally silenced around the time of birth). It is widely accepted that if pharmaceutical means can be found for reactivating the foetal haemoglobin genes then many patients would benefit. The regulation of the foetal globin genes, like most human genes, is complicated and there are few obvious means of increasing their activity. Nevertheless, it is believed that by investigating the molecular mechanisms by which they are controlled it will be possible to devise therapeutic agents that mimic these mechanisms or to develop agents that prevent the shutdown of the foetal genes around birth. To this end we have been working on the molecules that regulate the activity of the haemoglobin genes. We have recently cloned a number of DNA-binding proteins, and their co-factors, that appear to be involved in silencing foetal globin gene expression. This grant proposal is concerned with learning how these new molecules operate to silence gene expression as a first step towards designing agents that will prevent the silencing.Read moreRead less
Functional Characterisation Of Regulators Of Human Globin Gene Switching
Funder
National Health and Medical Research Council
Funding Amount
$232,131.00
Summary
Red blood cells produce haemoglobin, a tetramer of two alpha globin chains and two beta-globin chains. Haemoglobin reversibly interacts with oxygen in such a way that it efficiently shuttles oxygen between the lungs and the rest of the body. Integrity of the hemoglobin molecule, and red cells which carry it, is essential for life of all organisms with blood. The alpha-globin and beta-globin chains that make up haemoglobin are prodcued by red cell precursors in the bone marrow according to the ge ....Red blood cells produce haemoglobin, a tetramer of two alpha globin chains and two beta-globin chains. Haemoglobin reversibly interacts with oxygen in such a way that it efficiently shuttles oxygen between the lungs and the rest of the body. Integrity of the hemoglobin molecule, and red cells which carry it, is essential for life of all organisms with blood. The alpha-globin and beta-globin chains that make up haemoglobin are prodcued by red cell precursors in the bone marrow according to the genetic blueprint (genes) that are inherited. Genetic disorders resulting from defects in the beta-globin gene are the most common inherited disorders of man. Children who fail to make beta-globin have a disease known as beta-thalassaemia. They are transfusion dependent from ~ 6 months of age and need intensive chelation therapy (infusions) to avoid the serious consequnces of iron overload. The average life expectancy in Western cultures is ~ 30 years. There is no cure. In third world countries where a reliable blood supply is unavailable, death occurs earlier. Patients are aften infected with blood born viruses such as hepatitis B, hepatitis C and the AIDS virus, HIV. Sickle cell anaemia is also a very common disease. It is due to a single DNA base mutation at in the beta-globin gene that results in production of normal amounts of a defective beta-globin molecule (HbS). In low oxygen, HbS molecules polymerize in red cells and irreversibly damage them. These red cells get trapped in small blood capillaries throughout the circulation causing small infarcts which results in severe pain and organ damage. The life expectancy is <2 years in the thrid world and ~20-30 years in the west. The irony of these two diseases is that there is a perfectly normal fetal globin gene that has been silenced during fetal life. This grant aims to understand the mechanism of the switch from fetal to adult globin gene usage so it can be reversed in adults with b-thalassemia and sickle cell diseaseRead moreRead less
This is a study of the biological system of epigenetics. Every cell in our body has the same genetics, or library of information contained in the form of DNA sequence. Epigenetics is the system that controls how this DNA is used in a particular situation, or what books are opened and read. During embryonic development, cells know what they want to become, e.g., a muscle cell, and, once they take on an identity, remember that they are when they duplicate themselves during growth. Epigenetics does ....This is a study of the biological system of epigenetics. Every cell in our body has the same genetics, or library of information contained in the form of DNA sequence. Epigenetics is the system that controls how this DNA is used in a particular situation, or what books are opened and read. During embryonic development, cells know what they want to become, e.g., a muscle cell, and, once they take on an identity, remember that they are when they duplicate themselves during growth. Epigenetics does not achieve this through changing genetics the library always stays intact. Rather, it acts by using proteins or chemicals to make DNA functional in one way, or another. Genomic imprinting is a special type of epigenetics. While an embryo has received identical genetic information from each of its parents, the epigenetic information received from each parent was not entirely the same. Some genes which behave differently according to what parent they came from. For example, a gene that makes a growth factor protein is active only if received from the father. If received from the mother, it is inactive, and makes no protein. Genes behaving in this way are known as imprinted genes. We are trying to discover what epigenetic mechanisms are behind this behaviour of imprinted genes. One way we are approaching this problem is to study germ cells the cells giving rise to eggs and sperm. These cells are unusual in that their imprinted genes behave in the same way regardless of whether they were received from the mother or father, i.e., like any other gene. If we can understand why this is the case, we will be better able to understand why imprinted genes behave the way they do in the rest of the cells of the body. Broadly, the mechanisms we uncover should further our understanding of germ cell development, gene expression, and disease. Perturbations in the epigenetic profile are likely causes of human disease, including cancer.Read moreRead less
The Establishment Of Epigenetic Marks At Metastable Epialleles In The Mouse
Funder
National Health and Medical Research Council
Funding Amount
$372,750.00
Summary
Occasionally, identical twins are found to have distinctly different characteristics, such as eye colour or severity of genetic disease, that clearly cannot be explained by their genetic makeup, and are unlikely to be the result of environmental differences. In genetically identical mice, similar cases exist, where some mice have a yellow coat and others a brown coat. In instances such as these, a growing body of evidence suggests that certain modifications to genes are responsible. These modifi ....Occasionally, identical twins are found to have distinctly different characteristics, such as eye colour or severity of genetic disease, that clearly cannot be explained by their genetic makeup, and are unlikely to be the result of environmental differences. In genetically identical mice, similar cases exist, where some mice have a yellow coat and others a brown coat. In instances such as these, a growing body of evidence suggests that certain modifications to genes are responsible. These modifications are not traditional DNA mutations, but are chemical modifications of the basic sequence. Currently, we do not know when these DNA modifications are established during foetal development. We will use the mouse coat colour gene mentioned above to investigate when the different physical characteristics are established in embryonic development. Indeed, there is increasing evidence that critical periods exist in human foetal development where minor environmental or nutritional changes can affect long-term health of the adult. Perhaps the establishment of the DNA modifications are under an environmental or nutritional influence. Further study of when and how the DNA modifications are set-up during embryonic development is necessary in order to understand these events.Read moreRead less
A Random Mutagenesis Screen To Identify Modifiers Of Epigenetic Phenomena In The Mouse.
Funder
National Health and Medical Research Council
Funding Amount
$680,750.00
Summary
In recent months, both the human and mouse genome projects have been completed. The main focus now for mammalian geneticists is to discover the function of the genes sequenced in these initiatives. One way to achieve this goal is by random mutagenesis followed by screening of mice for novel phenotypes. In the mouse, ethylnitosourea (ENU) is a chemical that can be used to perform the mutagenesis. ENU causes mutations in sperm. We are using ENU mutagenesis to search for genes that modify epigeneti ....In recent months, both the human and mouse genome projects have been completed. The main focus now for mammalian geneticists is to discover the function of the genes sequenced in these initiatives. One way to achieve this goal is by random mutagenesis followed by screening of mice for novel phenotypes. In the mouse, ethylnitosourea (ENU) is a chemical that can be used to perform the mutagenesis. ENU causes mutations in sperm. We are using ENU mutagenesis to search for genes that modify epigenetic states. Epigenetic modifications are alterations in the genome that do not change the DNA sequence, yet silence the expression of genes. Silencing occurs on a cell-by-cell basis within a tissue resulting in mosaic expression. Silencing can also occur between individuals of the same genetic makeup. For example, identical twins are occasionally found that have distinctly different characteristics, such as eye colour or severity of genetic disease. These differences may be the result of variable epigenetic modifications. However, very little is known about how these variable epigenetic modifications are controlled. We wish to find the proteins involved in establishing and maintaining epigenetic states. It is likely that these processes play a fundamental role in the determination of phenotype, both in normal development and disease.Read moreRead less